SPNT:NYSESiriusPoint Ltd. Analysis

SiriusPoint (SPNT) is trading at $24.65, comfortably above its 20‑day SMA (23.75) and 50‑day SMA (23.08) while still below the 52‑week high of $25, indicating a bullish short‑term trend supported by a 64‑point RSI and a bullish MACD histogram. Technical indicators are reinforced by a solid support level at $22.59 and a modest upside to the $25 resistance, suggesting limited near‑term price appreciation but a stable platform for further gains.
Fundamentally, the company trades at a PE of 6.2 versus an industry average of 17.6, boasts a ROE of 23%, and carries more cash ($975M) than debt ($703M), delivering a strong combined ratio of 88.9% in Q1 2026. Recent strategic moves—including the launch of a Crisis Solutions platform and the formation of a Fine Art & Specie team—signal diversification and potential revenue growth, while management highlighted $71M of underwriting income and lower catastrophe volatility.
The stock’s beta is low (≈0.14), volatility over the past 30 days is elevated at 32%, and the Fear & Greed Index sits at “Extreme Greed,” reflecting market optimism. Together, these factors paint a picture of an undervalued, financially resilient insurer with upside potential but exposure to insurance‑specific cyclicality.